# The Efficacy of Salvage BGD With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD

> **NCT03615664** · PHASE2 · COMPLETED · sponsor: **Polish Lymphoma Research Group** · enrollment: 115 (actual)

## Conditions studied

- Hodgkin's Lymphoma

## Interventions

- **DRUG:** Bendamustine
- **DRUG:** Gemcitabine
- **DRUG:** Dexamethasone
- **DIAGNOSTIC_TEST:** PET/CT
- **PROCEDURE:** Autologous Stem Cell Transplant

## Key facts

- **NCT ID:** NCT03615664
- **Lead sponsor:** Polish Lymphoma Research Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-06
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03615664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03615664, "The Efficacy of Salvage BGD With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03615664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*